PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24843385-10	2014	The levels of plasminogen activator inhibitor-1, high sensitivity C-reactive protein, and urinary 8-hydoroxydeoxyguanosine were reduced significantly by repaglinide treatment.	repaglinide	153-164	serpin family E member 1	Homo sapiens	14-47	
16142016-8	2005	At time 120" of meal test, repaglinide vs glimepiride administration was associated with a significant decline in plasma triglycerides, free fatty acids, fibrinogen, Plasminogen Activator Inhibitor-1, plasmin-alpha(2)-antiplasmin complex, thrombin-antithrombin complex, TBARS levels and increase in plasma HDL-cholesterol levels.	repaglinide	27-38	serpin family E member 1	Homo sapiens	166-199	
12749508-14	2003	Repaglinide significantly lowered levels of Lp(a), PAI-1, and Hcy after 12 months (all, P < 0.05 vs baseline).	repaglinide	0-11	serpin family E member 1	Homo sapiens	51-56	
16142016-4	2005	Lowering in plasma PAI-1 and PAP levels was significantly greater in repaglinide group.	repaglinide	69-80	serpin family E member 1	Homo sapiens	19-24